7.445USD+1.15%Mkt Cap: 2.73B $P/E: —Today
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-00…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap2.73B $
Enterprise Value2.52B $
Revenue (TTM)4.47M $
Gross Profit-70.62M $
Net Income (TTM)-660.05M $
Revenue/Share0.0140 USD
Last Price7.445 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-15.14
PEG—
EV/EBITDA-17.93
EV/Revenue564.58
P/S615.34
P/B15.52
EPS (TTM)-2.79
EPS (Forward)-0.49
52W Range
7.240100% of range7.370
52W High7.370 USD
52W Low7.240 USD
Profitability
Gross Margin0.00%
Oper. Margin-2590.43%
EBITDA Margin0.00%
Profit Margin-16142.02%
ROE-297.49%
ROA-225.49%
Growth
Revenue Growth137.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-102.67M $
CapEx (TTM)10.87M $
FCF Margin-1669.72%
FCF Yield-2.74%
Net Debt-221.52M $
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.01
Current Ratio8.58
Quick Ratio8.29
Book Value/Sh0.4780 USD
Cash/Share0.6090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.100 USD
Upside (mean)+8.8%
Target Range7.450 USD – 9.250 USD
$7.450+8.8% to mean$9.250
# Analysts7
Ownership
Shares Out.370.86M
Float308.41M
Insiders2.18%
Institutions53.03%
Short Interest
Short Ratio1.0d
Short % Float6.33%
Short % Out.5.37%
Shares Short19.86M
Short (prev mo.)30.26M
Technical
SMA 505.999 (+24.1%)
SMA 2004.506 (+65.2%)
Beta1.55
S&P 52W Chg18.16%
Avg Vol (30d)8.34M
Avg Vol (10d)6.41M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—